Navigation Links
Press statement on new CDC MMWR on Klebseilla pneumonia Carbapenemase-producing organisms
Date:3/18/2009

The Centers for Disease Control and Prevention (CDC) today released new infection control recommendations on Klebseilla pneumoniae Carbapenemase (KPC)-Producing Organisms, one of the most treatment-resistant gram-negative bacterium. Recent studies have shown that infections with these highly resistant bacteria are a growing problem in health care settings. In Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities published in the MMWR, CDC recommends an aggressive infection control approach to limit the emergence of these organisms.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"The new guidelines highlight the need to educate clinicians and public health professionals about the importance of screening for Klebsiella pneuomoniae Carbapenemase (KPC)-Producing Organisms. If hospitals follow the CDC guidelines to detect and identify Klebsiella and Carbapenemase, then we can potentially halt the transmission of a highly treatment-resistant Gram-negative organism and prevent a large scale public health problem.

While KPC is still rare and occurs only sporadically in most parts of the country, an aggressive infection control approach needs to be taken now. These new guidelines suggest that facilities start by checking microbioloigy results for the last six to twelve months. Facilities finding evidence of these organisms should conduct a focused risk assessment or examine high-risk wards including intensive care units to make sure there is no evidence of ongoing transmission. The strategy for testing uses a selection process to get rid of most other organisms and focuses on the ones that are likely to be treatment-resistant including Carbapenem resistant Klebsiella.

For example, Israel has had widespread public health problems with these organisms, yet has managed to contain them in a short time period by implementing targeted screening and prevention practices.

The focused screening is important because there is a need to be both proactive in preventing the spread of KPCs yet judicious and mindful of limited hospital resources."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related biology news :

1. Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
2. American Chemical Societys weekly PressPac -- March 11, 2009
3. New tracking tags are providing fish-eye views of ways to manage depressed fisheries
4. Is it really only our kidneys that control blood pressure?
5. Researchers take first look at the genetic dynamics of inbreeding depression
6. Study suggests salt might be natures antidepressant
7. Children seriously affected when a parent suffers from depression
8. Chantix side effects no worse with depression history
9. Suppressing cancer with a master control gene
10. Press statement on new CDC MRSA study from SHEA president
11. Molecule that suppresses immune response under study in type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... February 3, 2016 --> ... research report "Automated Fingerprint Identification System Market by Component ... Application (Banking & Finance, Government, Healthcare, and Transportation) and ... the market is expected to be worth USD 8.49 ... between 2015 and 2020. The transformation and technology evolution ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove announced ... the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to ... heard throughout the drug regulatory review process. , “Adding Diane Dorman is just ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of Medical Geneticists and  ... Experiences SHPG ) ... of children born with rare diseases, as well as the future ... a new initiative designed to positively affect the lives of children ... disease care. --> To mark the company,s founding 30 ...
(Date:2/8/2016)... 2016 Should antibiotic bone cement products be ... prevent infection after standard total hip or knee replacement ... Institute have been fielding a lot lately. ... Line?" --> "Antibiotic Bone Cement: ... --> While there isn,t a simple answer, ...
(Date:2/8/2016)... ... February 08, 2016 , ... Thomas J. Todorow has joined ... President for Corporate Services and the Chief Financial Officer at The Children’s Hospital ... Treasury, Managed Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP ...
Breaking Biology Technology: